Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Selective Demethylation and Phosphitylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107556355B discloses a novel synthesis route for high-purity nucleoside diphosphite amides, enabling superior quality control in antisense drug manufacturing.